Investing.com - Collplant ADR reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Collplant ADR announced earnings per share of $-0.3 on revenue of $691K. Analysts polled by Investing.com anticipated EPS of $-0.1 on revenue of $3.1M.
Collplant ADR shares are up 60.54% from the beginning of the year, still down 28.73% from its 52 week high of $24.26 set on February 11. They are outperforming the Nasdaq which is up 13.19% from the start of the year.
Collplant ADR shares lost 1.31% in intra-day trade following the report.
Collplant ADR follows other major Healthcare sector earnings this month
Collplant ADR's report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
Eli Lilly had missed expectations on August 3 with second quarter EPS of $1.87 on revenue of $6.74B, compared to forecast for EPS of $1.89 on revenue of $6.6B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar